Cargando…
In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia
SIMPLE SUMMARY: Hematological neoplasms afflict millions of children and adults yearly and are often uncurable due to refractory illness and recurrence. Therefore, new treatment approaches are required. The proto-oncogene c-MYC has been linked to carcinogenesis, particularly in hematological maligna...
Autores principales: | Boulos, Joelle C., Chatterjee, Manik, Shan, Letian, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452460/ https://www.ncbi.nlm.nih.gov/pubmed/37627164 http://dx.doi.org/10.3390/cancers15164136 |
Ejemplares similares
-
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
por: Boulos, Joelle C., et al.
Publicado: (2021) -
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma
por: Boulos, Joelle C., et al.
Publicado: (2023) -
PLANTAR WARTS TREATED WITH TOPICAL ADAPALENE
por: Gupta, Ramji
Publicado: (2011) -
Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing
por: Fidan, Ozkan, et al.
Publicado: (2022) -
Photostability Testing of a Third-Generation Retinoid—Tazarotene in the Presence of UV Absorbers
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2020)